[Previous Months][Date Index][Thread Index][Join - Register][Login]
[Message Prev][Message Next][Thread Prev][Thread Next]
[IP] More info on a noninvasive glucose monitor
I just came across the following news release about a noninvasive glucose
monitor that sounded promising. Still much to do before it can be offered
for sale, but it sure looks interesting!
San Francisco Bay Area
Instrumentation Metrics Preliminary Clinical Trial Data Suggests Success In
Using Near-Infrared Spectroscopy to Non-Invasively Measure Blood Glucose
February 22, 2001
Interim Results From the Largest Study of Its Kind
Are Presented at Annual AIDPIT Meeting
CHANDLER, Ariz., Feb. 21 /PRNewswire/ -- Instrumentation Metrics, a
Chandler, Arizona-based medical device company, recently presented interim
data from a large scale (128 adult subjects), multi-center trial at the
prestigious Artificial Insulin Delivery/Pancreas and Islet Transplantation
(AIDPIT) meeting in Igls, Austria, held January 28-30, 2001. Instrumentation
Metrics' preliminary results suggest that, over a large subject sample, the
company's prototype noninvasive blood glucose monitor is the first device of
its kind to accurately and precisely measure blood glucose levels in people
with diabetes. The study is expected to conclude in March, with final data
and conclusions to be released by the end of June.
"Our encouraging preliminary data represents an important strategic
milestone for Instrumentation Metrics, and provides validation that we are
on a direct and focused path to develop a commercially viable instrument,"
stated Donald Hetzel, Ph.D., President and CEO of the company. "We have
embarked on a trial of this size and scope to leave no doubt that our
technology is truly effective at providing accurate noninvasive measurements
of blood glucose over long time periods."
Instrumentation Metrics' investigational blood glucose monitor utilizes
near-infrared (NIR) diffuse reflectance spectroscopy to accomplish a
noninvasive measurement. NIR spectroscopy in this application is the process
of shining low-level light onto the forearm. A portion of the light, and the
corresponding information within, is then reflected back to a detector and
translated into blood glucose values.
"Using NIR technology to determine accurate measurements of blood glucose
levels in people with diabetes requires an extremely complex integration of
many disciplines, including tissue optics, spectroscopy, multivariate
statistics, engineering and analytical chemistry, among others," said
Stephen Monfre, Ph.D., Instrumentation Metrics, Vice President of Research
and Development. "This data demonstrates that our accuracy in measuring
blood glucose is within the acceptable industry standards and far exceeds
the accuracy of any predecessor products."
Analysis of data derived from the first subjects to complete the study shows
that the technology has been able to accurately provide forward-looking
measurements of blood glucose levels for at least eight weeks after the
device was personally calibrated to the user. Preliminary results have been
found to be highly accurate, with 94 percent of the information falling
within the A and B ranges on the Clarke Error Grid, a universally accepted
method of data qualification for self-monitoring blood glucose devices.
About Instrumentation Metrics, Inc.
Chandler, Arizona-based Instrumentation Metrics, Inc. is committed to
advancing diabetes blood glucose monitoring and the science of diabetes
disease management through the creation and commercialization of the first
noninvasive blood glucose device. Once FDA approved, the technology will
provide a painless method to collect greater and more personalized data for
proactive use in controlling diabetes. Founded in 1995, Instrumentation
Metrics is a privately held company with more than 45 employees.
Instrumentation Metrics' products are investigational devices and are
limited by federal law for investigational use.
For further information, please contact Jessica Morris, ext. 140,
email @ redacted, or Megan Taylor, ext. 165,
email @ redacted, both of Fischer & Partners, Inc., 310-577-7870,
for Instrumentation Metrics, Inc.; or Andrew Cone of Instrumentation
Metrics, Inc., 480-755-9483, email @ redacted
SOURCE Instrumentation Metrics, Inc.
for HELP or to subscribe/unsubscribe, contact: HELP@insulin-pumpers.org
send a DONATION http://www.Insulin-Pumpers.org/donate.shtml